BioVie (NASDAQ:BIVI) reported quarterly earnings results on February 06, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.77, beating the consensus estimate of $-0.81 by $0.04 per share. Revenue came in at , meeting the estimate of .
BioVie's stock moved following the earnings release. The stock currently trades at $1.15 with a market capitalization of $11.5M.


